Open surgery remains a valid option for the treatment of recurrent carotid stenosis  by Coscas, Raphaël et al.
Open surgery remains a valid option for the
treatment of recurrent carotid stenosis
Raphaël Coscas, MD, Badre Rhissassi, MD, Noémie Gruet-Coquet, MD, Thibault Couture, MD,
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Objective: The choice between open surgery (OS) and transluminal carotid angioplasty with stenting (CAS) for the
treatment of primary carotid stenosis remains controversial. However, CAS is considered a valid option for selected cases,
such as recurrent carotid stenosis (RCS). Tertiary RCS seems to be a concerning issue after CAS but few large reports
focused on the durability of CAS and OS. We report our early and long-term results with OS for RCS.
Methods: From 1989 to 2006, perioperative data regarding 4245 consecutive surgical carotid reconstructions was
prospectively collected. Patients whose indication was RCS were subjected to further analysis. Indications for surgery
were symptomatic RCS >50% or asymptomatic RCS >80%. Freedom from neurologic event was defined as the absence
of any ipsilateral symptom at any time after the procedure. Kaplan-Meier analysis was used to estimate freedom from
reintervention, freedom from restenosis >50% and occlusion, freedom from neurologic event and survival.
Results: A total of 119 patients (2.8%) with RCS underwent OS. The average time from the primary OS was 59.4 54.5
months (range, 2-204). Forty-nine patients (41%) were symptomatic. In 103 patients (87%), the technique did not differ
from a primary approach. Postoperative (<30 days) combined stroke and death rate was 3.3%. Cranial nerve injury
occurred in 5 cases (4.2%). With a mean follow-up of 53 48 months (range, 1-204), 3 patients had an ipsilateral stroke
(including one hemorrhagic stroke) and 7 were diagnosed with a tertiary RCS>50%. At 5 years, Kaplan-Meier estimates
of freedom from reintervention, freedom from restenosis and occlusion, freedom from neurologic event, and survival
were 99%, 91%, 89%, and 91%, respectively.
Conclusion: OS for RCS is not a high-risk procedure and provides excellent long-term results, with low rates of tertiary
RCS and reinterventions. The comparison between OS and CAS in this indication suffers from the absence of
standardized follow-up paradigms after primary OS and the lack of prospective randomized trial comparing the two
techniques. Despite these limitations in the available data, we conclude that OS should remain the first line therapy when
treatment of RCS is indicated. (J Vasc Surg 2010;51:1124-32.)Carotid artery endarterectomy (CAE) has been dem-
onstrated to be the best option to prevent stroke for pa-
tients with high-grade symptomatic1,2 or asymptomatic3,4
carotid stenosis. Despite excellent immediate results, recur-
rent carotid stenosis (RCS) remains a concern whose inci-
dence is dependent upon the surgical technique, the
method of imaging utilized for surveillance, the definition
of RCS, and the length of follow-up.5
A controversy remains regarding the choice between
open surgery (OS) and transluminal carotid angioplasty
with stenting (CAS) for the treatment of primary carotid
stenosis. Although early results of the stent-protected an-
gioplasty vs carotid endarterectomy (SPACE) trial and the
Endarterectomy versus Angioplasty in Patients with Symp-
tomatic Severe Carotid Stenosis (EVA-3S) trial were in
favor of OS for the treatment of symptomatic cases,6,7
intermediate-term results of these two prospective random-
ized trials demonstrated similar clinical outcomes for both
techniques.8,9 In the EVA-3S trial, one main reason for the
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1124difference observed during the early postoperative period
was a low rate of complications after primary CAE in
specialized centers.6 Therefore, it has been suggested that
CAS could provide a significant advantage in situations
where OS provides its worst results.
The treatment of RCS has been considered to be a
high-risk procedure. The dissection of the carotid artery in
a previously operated field would be expected to carry a
higher risk of local complications such as cranial nerve
injury (CNI) and wound hematoma. Difficulties in control-
ling the carotid artery could increase the risk of cerebral
emboli. Using a puncture distant from the site of the RCS,
CAS has been suggested to be an interesting alternative in
these situations. Despite the lack of prospective compara-
tive trials, its early results seemed to compare favorably with
OS in the management of RCS.10,11 However, several
authors emphasize that the surgical approach to RCS may
not be technically demanding and historic series reporting
on OS to treat RCS have concluded that this procedure
provides early results comparable to those reported with
primary CAE.12,13
Long-term results of both techniques have not been
well studied. The durability of CAS for RCS is poorly
known, whereas only two recent large series (100 pa-
tients) reported on late results of OS.12,13 These consider-
ations are paramount because patients with RCS are often
in their seventh or eighth decades and may be expected to
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tions of public authorities and vascular societies regarding
management of RCS could not conclude whether CAS or
OS was the most appropriate treatment for menacing RCS
because of the absence of comparative trials and the lack of
long-term follow-up data.14,15 The aim of this study is to
report our results with OS in the management of RCS,
focusing on long-term outcomes.
MATERIALS AND METHODS
Data collection and patient selection. From January
1989 to December 2006, perioperative data of 4245 con-
secutive carotid reconstructions performed in our depart-
ment were prospectively collected in a database. Patients
whose intervention was a redo procedure were identified
and only cases whose indication was RCS were selected and
subjected to further analysis. Patients who underwent an-
other concomitant vascular repair at the time of the RCS
repair were excluded. Repairs of intrathoracic supra-aortic
trunks were excluded, as were aneurysmal degenerations of
previous endarterectomy patches.
Surgical management. All patients referred for the
management of RCS underwent confirmation of the recur-
rence using twodifferent imagingmethods including a duplex
ultrasound scan in all cases associated with a non-operator-
dependent method (CT scan, MRI, and/or carotid angiog-
raphy). Surgery was indicated for patients with symptomatic
stenosis 50% and high-grade asymptomatic stenosis
80% (North American Symptomatic Carotid Endarterec-
tomy Trial [NASCET] criteria). Patients presenting with
intracranial stenosis that exceeded the severity of the ex-
tracranial stenosis, severe disability from stroke, short life
expectancy, or inability to give informed consent were not
offered surgery.
Interventions for RCS were performed under general
anesthesia by a senior surgeon (L.C., E.K., F.K.). The
surgical approach always consisted of a redo anterior cervi-
cotomy along the sternocleidomastoid muscle, as for a
primary intervention. Technically, we usually preferred to
first control the common carotid artery (CCA) and the
internal carotid artery (ICA) in nondissected portions, and
then to dissect the carotid bulb after clamping. After iden-
tification and control of the main carotid vessels, a systemic
bolus of 0.5 mg/kg of unfractioned heparin was adminis-
tered intravenously before clamping. Occlusion of the ex-
ternal carotid artery was frequently obtained through the
inflation of a 5F intravascular Fogarty catheter (Edwards
Lifesciences Corporation, Irvine, Calif). Selective shunting
was used in the presence of preoperative severe stenosis
and/or occlusion of other major cerebral vessels (contralat-
eral carotid artery, vertebral arteries) or intraoperative find-
ing of nonpulsatile reflux from the distal ICA. Carotid
artery reconstruction depended on the severity and extent
of the lesion and was adapted to each case at the discretion
of the vascular surgeon. Preference was given to the sim-
plest procedure. Dacron patch (Hemacarotid Patch; Inter-
vascular Datascope, La Ciotat, France) angioplasty with or
without intimectomy was used whenever it was possible. Incases of obvious smooth plaque suggesting myointimal
hyperplasia, intimectomy was not performed and a simple
patch angioplasty was performed. When the extent of the
lesion rendered the use of a bypass mandatory, a prosthetic
polytetrafluoroethylene graft (Thin-walled tubular graft;
GoreTex, Flagstaff, Ariz) was used, except in the presence
of a distal ICA with reduced diameter (3.5 mm) where a
saphenous vein graft was used. At the end of the procedure,
selective angiography was performed to assess the patency
of the repair.
Postoperatively, all patients returned to a conventional
hospital ward and were generally discharged at day 3-4 in
the absence of any complication. Unless contraindicated,
an oral antiplatelet agent (aspirin 75-250 mg daily or
clopidogrel 75 mg daily) was administered to all patients
before surgery and life-long.
Follow-up. Duplex ultrasound scan was performed at
1 month, 6 months, 12 months, and yearly in the absence
of a neurologic event and/or duplex scan anomaly. Data
regarding long-term survival, neurologic state, and ana-
tomic lesions of the ipsilateral carotid were retrospectively
collected using medical charts and/or direct contact with
the patient (or his relatives in case of death) by phone call.
Freedom from neurologic event was defined as the absence
of any ipsilateral neurologic event (transient ischemic attack
and minor stroke included) after the procedure. Freedom
from restenosis was defined as the absence of tertiary ste-
nosis 50% (NASCET criteria) or occlusion of the ipsilat-
eral carotid artery on duplex ultrasound scan examination
during follow-up.
Statistical analysis. Demographic and periprocedural
characteristics are shown as number (%) or mean  SD.
Kaplan-Meier (KM) analysis was conducted to estimate
survival, freedom from restenosis, neurologic event, and
reintervention. The Statistical Package for the Social Sci-
ences (SPSS) software version 13.0 (SPSS Inc, Chicago, Ill)
was used for the statistical analysis.
RESULTS
One hundred nineteen consecutive patients operated
on for RCS were subjected to further analysis. This subset
represents 2.8% of the 4245 carotid reconstructions per-
formed in our department during the same period. All were
managed using OS and we never used CAS for RCS during
this period.
Demographics. Ninety-two patients (77%) were male
and the mean age at reintervention was 69.6  8.9 years
(range, 45-86). Cardiovascular risk factors were mainly a
history of tobacco use in 69% and hypertension in 68%
(Table I). Several patients presented with multifocal ath-
erosclerosis including coronary artery disease (any symp-
tom of heart ischemia, antecedent of coronary revascular-
ization, and/or positive stress test) in 33%, and peripheral
arterial disease (any peripheral arterial symptoms resulting
from occlusive disease and/or antecedent of limb revascu-
larization) in 22%. Thirty-four patients (29%) had a history
of vascular surgery including aortoiliac repair in 18 (12 for
aneurysm and 6 for occlusive disease), lower limb revascu-
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tion in 3, and superior mesenteric artery revascularization
in 2 cases. The primary carotid intervention was an endar-
terectomy with patch suture in 56 patients (47%), an end-
arterectomy with direct suture in 41 patients (34%), a
carotid bypass in 12 patients (10%), and an eversion in 10
patients (8%).
The RCS was located on the left carotid in 67 cases
(56%). The average time from the primary CAE to the
intervention for RCS was 59.4  54.5 months (range,
2-204). Forty-nine patients (41%) were symptomatic. The
main symptom was a transient ischemic attack (TIA) in 29
cases (including 8 amaurosis fugax) and a recent (3
months) cerebral infarction with or without superimposed
Table I. Preoperative clinical data of 119 patients who
underwent an open surgery for recurrent carotid stenosis
in our department (1989-2006)
Preoperative clinical data No. (%)
General
Total population 119 (100)
Age (years) 69.6  8.9
Time from primary CAE (months) 59.4  54.5
Male 92 (77)
Left side 67 (56)
Indication
Symptomatic 49 (41)
Including:
TIA 29 (24)
Stroke 20 (17)
Asymptomatic 70 (59)
Cardiovascular risk factors
Tobacco use 82 (69)
Hypertension 81 (68)
Dyslipidemia 70 (59)
Diabetes 19 (16)
Chronic renal insufficiency 12 (10)
Cardiovascular diseases
Coronaropathy artery disease 39 (33)
Including: myocardial infarction 15 (13)
Peripheral arterial disease 26 (22)
Previous arterial repair
Aortoiliac* 18 (15)
Lower limb 16 (13)
CABG 15 (13)
Renal artery 3 (3)
Superior mesenteric artery 2 (2)
CAE, Carotid artery endarterectomy; TIA, transient ischemic attack;
CABG, aorto-coronary bypass graft.
*Including, 12 aneurysms and 6 occlusive disease.
Table II. Intraoperative technical adaptations used in
our series
Intraoperative technical adaptations N (%)
Division of the occipital artery 9 (8)
Division of the posterior belly of the digastric muscle 5 (4)
Mobilization of the hypoglossal nerve 3 (3)
Division of the stylohyoid muscles 2 (2)
No technical adaptation 103 (87)TIA in 20 cases. The remaining 70 asymptomatic patientspresented with high-grade RCS80% and/or rapidly pro-
gressive RCS on duplex ultrasound scan study.
All patients underwent preoperative duplex ultrasound
scan, and the second imaging method was a CT scan in 24
cases (20%), anMRI in 20 cases (17%), and an angiography
in 75 cases (63%). Of note, no complication of carotid
angiography was noted in this series.
Surgical management. We always used an anterior
approach along the sternocleidomastoid muscle and never
used a retrojugular approach. In 103 patients (87%), the
approach was defined as “simple” by the senior surgeon and
did not necessitate any technical adaptation when com-
pared to a primary approach. In the remaining 16 cases
(13%), several technical modifications were used and are
summarized in Table II. Intimectomy with patch angio-
plasty was used in 63 patients (53%) whereas prosthetic
bypass graft was used in 31 patients (26%), isolated patch
angioplasty in 13 patients (11%), and others (saphenous
bypass, carotid eversion, resection-anastomosis) in 12 pa-
tients (11%). Macroscopic examination of the plaque re-
vealed myointimal hyperplasia in 45 patients (38%) and
Table III. Early postoperative complications (30 days)
in 119 patients who underwent an open surgery for
recurrent carotid stenosis in our department (1989-2006)
Early postoperative complications (30 days) No. (%)
Deaths 1 (0.8)
Including:
Stroke 1 (0.8)
Nonfatal neurologic complications 5 (4.2)
Including:
Stroke 2 (1.7)
Transient ischemic attack 3 (2.5)
Extra neurologic systemic complications 1 (0.8)
Including:
Myocardial infarction 1 (0.8)
Local complications 6 (5.0)
Including:
Hematoma evacuation 1 (0.8)
Cranial nerve injury 5 (4.2)
Table IV. Late complications (30 days after the
procedure) in 118 patients who survived the intervention
after a mean follow-up of 53  48 months
Late complications (30 days) No. (%)
Ipsilateral stroke 3 (2.5)
Including:
Ischemic 2 (1.7)
Hemorrhagic 1 (0.8)
Transient ischemic attack 1 (0.8)
Recurrent occlusive disease 7 (5.9)
Including:
50% to 80% stenosis 5 (4.2)
80% to 99% stenosis 1 (0.8)
Ipsilateral carotid occlusion 2 (1.7)*
Tertiary intervention 2 (1.7)
*Including one asymptomatic occlusion discovered during the immediate
post-operative period.atherosclerosis in the other cases.
tenos
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died during the 30-day perioperative period (Table III).
This death was secondary to an immediate severe postop-
erative ipsilateral ischemic stroke in an 85-year-old female
who underwent a prosthetic bypass graft for a symptomatic
RCS. The mechanism of this event remains poorly under-
stood because good reflux was noted intraoperatively
(clamping time 30 minutes) and postoperative angiogra-
phy did not demonstrate any clear anomaly of brain perfu-
sion. Nonfatal stroke occurred in 3 cases (2.5%). All were
ischemic and ipsilateral to the operated carotid artery
(Rankin score: 3, 3 and 4, respectively). Three patients
(2.5%) experienced a TIA. One additional patient suffered
a nonfatal postoperative myocardial infarction. Conse-
quently, the rate of combined perioperative mortality and
stroke morbidity (CMSM) is 3.3% for our series. Local
operative morbidity consisted in 5 cases (4.2%) of CNI
including recurrent laryngeal nerve palsy in 2 cases, hypo-
glossal nerve injury in 2 cases, and facial nerve injury in 1
case. All but 1 had completely recovered 1 year after the
Fig. (a) Actuarial plots of freedom from restenosis, (b)
events and (d) survival after open surgery for carotid resintervention. One patient (0.8%) with wound hematomanecessitated an emergent surgical drainage. All but one
(0.8%) repaired ICA were patent on the predischarge du-
plex ultrasound scan. Two external carotids were occluded
(1.7%). These 3 last patients did not suffer any neurologic
symptoms.
Follow-up. With a mean follow-up of 53  48
months (range, 1-204), 39 patients were lost and 25 pa-
tients expired (Table IV and Fig). Two patients experi-
enced ipsilateral ischemic stroke at 14 and 24 months. The
first one was related to an ipsilateral carotid occlusion and
the second presented with a 40% tertiary RCS. Other
complications were one ipsilateral hemorrhagic stroke at
2 months, and one contralateral ischemic stroke at 70
months. Recurrent occlusive disease was found in 7 pa-
tients: 5 patients were noted to have a 50% to 80% tertiary
RCS at 6, 39, 41, 49, and 73 months, 1 patient was
discovered to have a 90% tertiary RCS at 78 months, and 1
patient was found to have an asymptomatic total occlusion
of the ICA at 132 months. From those, 2 patients were
given tertiary open surgery for RCS. One was for a severe
om from reintervention, (c) freedom from neurologic
is.freedasymptomatic 90% RCS and the second was indicated for
80%
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last patient was the only one to experience a TIA during
follow-up. The main late complications are summarized
in Table IV. At 5 years, estimated rates of freedom from
tertiary RCS 50%, freedom from reintervention, free-
dom from any neurologic event, and survival were 91%,
99%, 89%, and 91%, respectively. KM curves are pre-
sented in Fig, a-d.
DISCUSSION
The long-term results observed in this large series assess
the durability of OS in the treatment of RCS, and contrast
with the absence of long-term data regarding CAS for RCS.
For the last 30 years, CAE has become a widely used
procedure in preventing stroke. At the same time, improve-
ment of noninvasive imaging techniques (duplex ultra-
Table V. Early and long-term results of consequent series
stenosis
Author Period
No.
patients
(carotids)
Early results (30
Nonfatal
stroke
%
Death
%
CM
Stoney et al16 1957-1975 29 (32) 0 3.1 3
Das et al17 1979-1983 61 (65) 1.5 3.1 4
Piepgras et al18 1972-1984 51 (57) 10.5 0 10
Bartlett et al19 1957-1985 94 (103) 1.9 1.9 3
Treiman et al20 1974-1991 162 (162) 2.5 1.2 3
Gagne et al21 1970-1991 42 (47) 0 0 0
Meyer et al22 1972-1992 82 (92) 5.4 4.3 9
AbuRahma
et al23 1988-1993 42 (46) 7 0 7
Coyle et al24 1983-1992 69 (69) 1.4 2.9 4
Raithel25 NS 64 (66) 3.1 0 3
O’Donnell
et al26 1983-1994 44 (48) 2.1 2.1 4
Ballinger et al27 1984-1995 67 (74) 1.4 1.4 2
Mansour et al28 1976-1996 69 (82) 4.8 0 4
Rockman et al29 1980-1996 74 (82) 3.7 0 3
Hill et al30 1993-1998 40 (40) 0 0 0
Gorlitzer et al31 1992-1998 41 (42) 2.4 0 2
Archie Jr32 1981-1999 66 (69) 2.9 0 2
O’Hara et al12 1989-1999 199 (206) 3.4 1 4
AbuRahma
et al33 1996-2000 58 (58) 3.4 0 3
Abou-Zamzam
et al34 1990-2000 56 (56) 3.6 1.8 5
Cho et al35 1990-2000 64 (66) 3 0 3
Rockman et al36 1992-2002 89 (89) 5.6 0 5
Stoner et al13 1989-2000 145 (153) 1.9 0 1
Mehta et al37 1981-2002 59 (59) 1.7 0 1
Jain et al38 1988-2005 80 (83) 0 1.2 1
De Borst et al39 1985-2006 72 (73) 0 0 0
Attigah et al40 1989-2007 NS (41) 4.9 0 4
Present series 1989-2006 119 (119) 2.5 0.8 3
CMSM, Combined operative mortality and stroke morbidity; CNI, cran
endarterectomy; NS, not stated.
Neurologic events includes both transient ischemic attack and stroke.
*Percentage of patients presenting with a 40% to 59%, a 60% to 79% and ansound scan, CT, andMRI) has allowed a better detection ofRCS after primary CAE. Studies regarding primary CAE
found a wide range in RCS incidence, depending on the
surgical technique (use of patch angioplasty or primary
closure), the method used for detection, the definition of
RCS, and the length of follow-up.5
Although the incidence of RCS is not clearly known,
the proportion of procedures performed for RCS is be-
tween 1% and 10% (2.8% in our department) of open
carotid procedures.12,13,16-40 However, RCS seems to be-
come amore common indication for CAS, as demonstrated
in the recent publication of the Society for Vascular Surgery
(SVS) vascular registry data: the treatment of an RCS
accounted for 1.2% of 3259 open surgical carotid proce-
dures vs 22.3% of 2763 CAS procedures between 2005 and
2007.41 This finding suggests the acceptance of CAS as
first-line therapy for RCS bymany surgeons despite the lack
0 vessels) reporting on open surgery for recurrent carotid
) Long-term results
CNI
%
Follow-up
(months)
Neurologic
event
%
Tertiary
RCS
%
Carotid
occlusion
%
Tertiary
CAE
%
NS NS 3.6 3.6 0 3.6
10.8 23 5.1 NS NS NS
NS NS NS NS NS NS
19.4 NS NS NS NS NS
2.4 35 (bypass)
64 (redo CAE)
3.7
26
9.3
21.9
5.6
1
0
19
4.5 54 9.8 4.5 9 7
NS NS NS NS NS NS
6.5 30.9 2.5 11 0 2.5
0 57 1.8 NS NS NS
4.7 NS NS NS NS NS
18.9 NS NS NS NS NS
15.7 48.2 10.9 NS NS NS
7.3 NS NS 6.1 NS NS
1.2 35 5.4 4.9 6.1 5.4
7.2 14 0 10 2.5 2.6
14.3 NS NS NS NS NS
4.3 50 6.1 13 0 4.5
1 51.6 8.7 5/7/3* 6 NS
17 22.1 NS 0 0 0
1.8 29 1.8 3.7 1.9 3.6
6 51.6 8 8 1.6 0
7.9 34.6 NS 6.3 1 8
1.3 52.8 NS 9.1 1.3 NS
3.4
45 (redo CAE)
19 (eversion) 0 3.4 0 1.7
7.2 50.9 4.6 NS 1.2 9.6
1.4 52 4.3 13.7 0 7.1
0 70.3 0 NS NS 9.7
4.2 53 8.5 5.0 2.5 1.7
rve injury; RCS, recurrent carotid stenosis 50%; CAE, carotid artery
to 99% tertiary RCS, respectively.(3
days
SM
%
.1
.6
.5
.8
.7
.7
.3
.1
.2
.8
.8
.7
.4
.9
.4
.4
.4
.6
.9
.7
.2
.9
.3
ial neof supporting evidence.
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most do not remains poorly understood. Although tobacco
use,42 female gender43 and hyperlipidemia44 were consid-
ered to be associated with RCS, these findings are contro-
versial45 and the natural history of RCS remains poorly
known. Some controversies exist about the risk of ipsilateral
stroke in the setting of an RCS.46,47 However, most au-
thors recommend treatment of lesions at high risk for
stroke, such as 50% stenosis for symptomatic RCS and
80% stenosis for asymptomatic RCS, and this was our
approach to the patients reported in this study. Although
these recommendations are similar to those for primary
CAE, the upper limit of acceptable stroke/death rate for
OS in the management of RCS has been defined to be
lower than 10%.48 In fact, all published series since 1995
have reported rates of CMSM between 0% and 5.6% and
our early results are consistent with those previously re-
ported (Table V).12,13,16-40
The surgical approach to RCS is reputed to be chal-
lenging. However, in our series, 103 (87%) of the 119 cases
were defined as “simple” by the senior surgeon and did not
require any technical adaptation in comparison to a primary
approach. In our practice, the surgical approach to an RCS
was not as technically demanding as surgeons supporting
CAS argue. Should care be taken to first control the carotid
in nonpreviously dissected areas, the rest of the procedure
does not carry any major technical difficulty. Moreover,
primary CAE is a commonly performed procedure with
which all vascular surgeons are familiar.
Our rate of CNI after OS for RCS is 4.2%, which is
Table VI. Early and long-term results of consequent serie
without stenting for recurrent carotid stenosis
Author Period
No.
patients
(carotids)
Early results (30
Nonfatal
stroke
%
Deaths
%
CM
New et al10 1998-NS 338 (358) 2.5 1.2 3
Vitek et al49 NS 99 (110) 3 1 4
Bowser et al50 1997-2002 50 (52) 2 2 4
Mc Donnell
et al51 1994-2001 25 (30) 0 3 3
De Borst
et al52 1998-2004 55 (57) 0 0 0
Bettendorf
et al53 2002-2006 33 (45) 3 0 3
Kadhkhodayan
et al54 1996-2005 75 (83) 3.6 0 3
Cuadra et al55 1996-2006 NS (118) 2.5 2.5 5
Mehta et al11 1996-2006 223 (NS) 1.4 0 1
Aburahma
et al56 2001-2008 112 (112) 0.9 0 0
Attigah et al40 1989-2007 NS (45) 0 0 0
Vos et al57 1997-2006 72 (72) 0 0 0
CMSM, Combined operative mortality and stoke morbidity; CNI, cran
endarterectomy; Neurologic events includes both transient ischemic attack
*RCS 80%.
**RCS 90%.consistent with other reports (Table V).12,13,16-40 Al-though CAS eliminates the risk of CNI, it must be empha-
sized that CNI are usually temporary as were all but one in
this study. Regarding the rate of immediate neurologic
and/or fatal complications, our results seem to be similar to
those reported in previous series (Table V)12,13,16-40 but
also to those published with CAS (Table VI).10,11,49-57
Indeed, apart from two series of OS with a CMSM of 10.5,
and 9.7%, respectively, all reported rates of CMSM were
between 0% and 6.3% regardless of the technique used
(Tables V and VI).
Few studies have focused on long-term durability of
both techniques. However, this consideration is of partic-
ular importance because of the age and expected longevity
of patients with RCS. To our knowledge, only two large
recent studies (100 cases) have reported long-term re-
sults for OS in RCS. O’Hara et al12 reported on a late
neurologic event rate of 8.7% in 196 patients undergoing
OS for RCS and followed for a mean of 4.3 years. More
than half of the late neurologic events were TIAs. At last
follow-up, 6% of the ipsilateral carotid arteries were found
to be occluded, 3% had an 80% to 99% stenosis, 7% had a
60% to 79% stenosis, 5% had a 40% to 59% stenosis, 16% had
a 20% to 39% stenosis, and 63% had a 0% to 19% stenosis.
Reporting on their results of secondary CAE over 153 RCS
(145 patients), Stoner et al13 found similar results with
rates of stroke and 50% tertiary RCS of 4% and 9.2%,
respectively, at 4.4 years. However, in a study published in
1992, Treiman et al20 reported 23 tertiary RCS of50% in
a series of 105 redo CAEs with 64-month follow-up. Our
30 vessels) reporting on transluminal angioplasty with or
) Long-term results
CNI
%
Follow-up
(months)
Neurologic
events
%
Tertiary
RCS
%
Carotid
occlusion
%
Tertiary
intervention
%
0 14 0 6.0 0 2.6
0 20 0 NS NS NS
0 22 2 16 0 8
0 20 0 10** 0 10
0 36 3.6 19 1.7 11.4
0 10 0 6.1* 0 NS
0 22.4 6 4.8 0 0
0 NS NS NS NS NS
0 NS NS NS NS NS
0 25 1.8 15 0 3.6
0 24.8 0 NS NS 2.2
0 NS NS NS NS NS
rve injury; RCS, recurrent carotid stenosis 50%; CAE, carotid artery
roke. NS, not stated.s (
days
SM
%
.7
.6
.1
.4
.9
ial ne
and strate of tertiary RCS is 5.0% with a mean follow-up of 53
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rate of tertiary RCS.
In contrast, the long-term results of CAS remain in
question. No large series describing the long-term results
of CAS has been published to date. At intermediate follow-
up, rates of RCS seem relatively high, perhaps leading to
even more challenging tertiary procedures. In the most
important published series of CAS for RCS (358 cases), the
rate of significant tertiary RCS 50% was 6% at 6 months,
which is similar to the rate observed in this series after 53
months of follow-up.10 Although the rate of tertiary RCS
after CAS is acceptable at 6-month follow-up, it can be
expected to increase with longer follow-up. Studies by
AbuRahma33 and de Borst52 have shown tertiary RCS rates
after CAS of 24% and 19% with mean follow-up periods of
18 and 36 months, respectively.32,52
In this single center report on OS for RCS, we were
limited by the retrospective nature of the analysis and
incomplete follow-up in an important proportion of pa-
tients. Moreover, although early results demonstrated
stroke and mortality rates in the range of those usually
reported for the treatment of primary carotid stenosis, it
should be emphasized that our patients were not routinely
examined by a neurologist during the postoperative period.
Also, our team has extensive experience with open carotid
procedures (350/year). Our results may not be general-
izable to lower volume centers.
The lack of prospective randomized trial, the heteroge-
neity of reported data through the literature (Table V and
VI) and the absence of standardized criteria for long-term
success can only allow for tentative conclusions regarding
the management of RCS. Clearly, late tertiary RCS is a
concerning problem, more common after CAS, and
follow-up paradigms should be defined as a function of the
technique used to treat RCS. In perspective medical ther-
apy, OS and CAS will improve their results in the following
years. The generalization of the prescriptions of antiplatelet
medications and statins,58 the refinement of perioperative
protocols after OS, and the use of new CAS technical
adjuncts like cerebral protection devices and drug-eluting
stents59 will lead the vascular surgical community to under-
take new evaluations in the future.
CONCLUSION
The results of this series support OS as a durable
treatment for RCS. The low rates of both perioperative and
long-term neurologic and anatomic complications ob-
served after OS compare favorably with those reported for
CAS and suggest that OS remains the preferred option for
the treatment of severe RCS. The comparison between OS
and CAS for RCS suffers from the absence of standardized
follow-up paradigms after primary OS and the lack of a
prospective randomized trial comparing the two tech-
niques. Considering these findings and the age and ex-
pected longevity of patients presenting with RCS, OS re-
mains the first line treatment for RCS in our center.AUTHOR CONTRIBUTIONS
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